date,title,source
Nov-05-18,REGENXBIO and Abeona Therapeutics Announce Worldwide Exclusive Licenses for the Treatment of Four Rare Lysosomal Storage Disorders Using NAV AAV9 Vector,PR Newswire
Nov-05-18,Abeona Therapeutics and REGENXBIO Announce Worldwide Exclusive Licenses for the Treatment of Four Rare Lysosomal Storage Disorders Using NAV AAV9 Vector,GlobeNewswire
Nov-07-18,What Kind Of Share Price Volatility Should You Expect For Abeona Therapeutics Inc (NASDAQ:ABEO)?,Simply Wall St.
Nov-09-18,"Abeona Therapeutics (ABEO) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-09-18,Abeona Therapeutics: 3Q Earnings Snapshot,Associated Press
Nov-09-18,Abeona Therapeutics Reports Third Quarter 2018 Financial Results and Business Highlights,GlobeNewswire
Nov-13-18,Abeona Announces Participation at the Jefferies 2018 London Healthcare Conference,GlobeNewswire
Nov-13-18,Edited Transcript of ABEO earnings conference call or presentation 12-Nov-18 3:00pm GMT,Thomson Reuters StreetEvents
Nov-26-18,Abeona Therapeutics Announces CEO Transition,GlobeNewswire
Nov-27-18,"Analysis: Positioning to Benefit within Abeona Therapeutics, Great Lakes Dredge & Dock, Imprimis Pharmaceuticals, Alliant Energy, Cytokinetics, and Aurinia Pharmaceuticals  Research Highlights Growth, Revenue, and Consolidated Results",GlobeNewswire
Nov-29-18,"Abeona Therapeutics to Host R&D Day on December 6, 2018",GlobeNewswire
Dec-03-18,Moving Average Crossover Alert: Abeona Therapeutics,Zacks
Dec-06-18,Abeona Therapeutics Details Pathway for Advancing Lead Clinical Programs and Unveils New Cystic Fibrosis Program Born from Next Generation AIM Vector Platform at 2018 R&D Day,GlobeNewswire
Dec-10-18,Why Abeona Therapeutics (ABEO) Could Be Positioned for a Slump,Zacks
Dec-11-18,Abeona Therapeutics (ABEO) in Focus: Stock Moves 5.5% Higher,Zacks
Dec-13-18,Is Abeona Therapeutics Inc (ABEO) A Good Stock To Buy?,Insider Monkey
Dec-25-18,How Should Investors Feel About Abeona Therapeutics Inc.s (NASDAQ:ABEO) CEO Pay?,Simply Wall St.
Jan-08-19,Abeona Therapeutics Strengthens Financial Leadership with New Executive Appointments,GlobeNewswire
Jan-31-19,Abeona Therapeutics to Present New Supportive Data for Novel Gene Therapies at WORLDSymposium,GlobeNewswire
Feb-01-19,"The Unknown Biotech Play that Could Deliver 400% Returns, or Much More",ACCESSWIRE
Feb-13-19,"New Research: Key Drivers of Growth for WPX Energy, ACADIA Pharmaceuticals, Lexicon Pharmaceuticals, MobileIron, Arrow Electronics, and Abeona Therapeutics  Factors of Influence, Major Initiatives and Sustained Production",GlobeNewswire
Feb-22-19,What Investors Should Know About Abeona Therapeutics Inc.s (NASDAQ:ABEO) Financial Strength,Simply Wall St.
Feb-22-19,Abeona Therapeutics Announces Participation in 8th Annual SVB Leerink Global Healthcare Conference,GlobeNewswire
Mar-18-19,Abeona Therapeutics: 4Q Earnings Snapshot,Associated Press
Mar-18-19,Abeona Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results,GlobeNewswire
Mar-19-19,Abeona Therapeutics Inc (ABEO) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Apr-04-19,Abeona Therapeutics Receives FDA Fast Track Designation for ABO-101 for Treatment of Sanfilippo Syndrome Type B (MPS IIIB),GlobeNewswire
Apr-15-19,Abeona Therapeutics to Present Data for ABO-401 in Cystic Fibrosis and Retinal Disorders at the American Society of Gene and Cell Therapy Annual Meeting,GlobeNewswire
Apr-16-19,Is Abeona Therapeutics's (NASDAQ:ABEO) 173% Share Price Increase Well Justified?,Simply Wall St.
Apr-30-19,Abeona Therapeutics to Report New Preclinical Data Demonstrating Therapeutic Potential of ABO-401 for Treatment of Cystic Fibrosis at American Society of Gene and Cell Therapy Annual Meeting,GlobeNewswire
May-01-19,Abeona Therapeutics Reports Preclinical Data Demonstrating Broad Therapeutic Potential of AIM Gene Therapy in Retinal Diseases at Association for Research in Vision and Ophthalmology Annual Meeting,GlobeNewswire
May-03-19,Earnings Preview: Abeona Therapeutics (ABEO) Q1 Earnings Expected to Decline,Zacks
May-07-19,Abeona Therapeutics Announces Participation in Upcoming Investor Conferences,GlobeNewswire
May-08-19,Abeona Therapeutics Announces Presentation of EB-101 Data at Society for Investigative Dermatology Annual Meeting,GlobeNewswire
May-10-19,Abeona Therapeutics: 1Q Earnings Snapshot,Associated Press
May-10-19,Abeona Therapeutics Reports First Quarter 2019 Financial Results and Business Highlights,GlobeNewswire
May-14-19,Abeona Therapeutics Inc (ABEO) Q1 2019 Earnings Call Transcript,Motley Fool
May-14-19,Abeona Therapeutics Treats First Patient in Second Cohort of Phase 1/2 Clinical Trial for ABO-101 in Sanfilippo Syndrome Type B (MPS IIIB),GlobeNewswire
May-15-19,Edited Transcript of ABEO earnings conference call or presentation 14-May-19 2:00pm GMT,Thomson Reuters StreetEvents
May-21-19,Abeona Therapeutics Announces FDA Clearance of Investigational New Drug Application for ABO-202 Gene Therapy in CLN1 Disease,GlobeNewswire
May-21-19,Edited Transcript of ABEO earnings conference call or presentation 14-May-19 2:00pm GMT,Thomson Reuters StreetEvents
Jun-18-19,Abeona Therapeutics Receives FDA Fast Track Designation for ABO-202 AAV9 Gene Therapy in CLN1 Disease,GlobeNewswire
